Higher doses of commonly prescribed ADHD medications may increase the risk of psychosis, a new study has found Getty High doses of commonly prescribed medications for ADHD have been linked to an ...
New research suggests that dosage plays a role in a rare side effect of A.D.H.D. stimulants. By Christina Caron Julianna McLeod, 26, had her first psychotic episode while taking Vyvanse for ...
People who are taking high doses of Adderall face an increased risk for developing psychosis or mania, according to a new Mass General Brigham study. The researchers from McLean Hospital ...
Teenagers and young adults taking high doses of prescription amphetamines may face a greater than fivefold increased risk of developing psychosis or mania, a new analysis suggests. The risk was ...
Hospitalized patients who took high doses of ADHD prescription amphetamines were five times likelier to develop psychosis and mania than patients not on the medication, a study found. The study of ...
New findings could help clinicians understand the course of delusions in youth and young adults that signal the need for a timely intervention to prevent a full relapse of psychosis. New findings ...
Prescribing rates for stimulants that treat attention-deficit/hyperactivity disorder (ADHD) have increased significantly over the past decade, with some of the ...
Unfortunately, high doses of stimulants like Adderall can increase the risk of psychosis or mania by more than fivefold, a new study finds. Advertisement Patients had a nearly 63% increased risk ...
Nonetheless, she said the study suggested that families of patients on high doses should be watchful for symptoms of psychosis or mania, including hearing voices, having delusions, or talking rapidly.
Sept. 12, 2024 – People taking some ADHD medications, such as Adderall, may face an increased risk of serious psychiatric issues like psychosis or mania, particularly when taking higher doses.
Taking a high dose of ADHD drugs is linked to more than five times greater risk of developing psychosis or mania, according to a new study published Thursday in the American Journal of Psychiatry.